Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Transdermal Patch market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Transdermal Patch market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Transdermal Patch market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Transdermal Patch products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Transdermal Patch products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Transdermal Patch market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Transdermal Patch development has been the leading industry trend of Transdermal Patch market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Transdermal Patch Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Fentanyl Transdermal Patch,Nicotine Transdermal Patch,Buprenorphine Transdermal Patch,Clonidine Transdermal Patch,Oxybutynin Transdermal Patch,Others |
| By Application Outlook |
Used to Stop Smoking Cigarettes,Used to Treat High Blood Pressure,Used to Relieve Severe Pain,Used to Treat an Overactive Bladder |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Hisamitsu Pharmaceutical,Novartis,Johnson & Johnson,Teikoku Pharma,Mylan,Actavis,Mundipharma,Henan Lingrui Pharmaceutical,Changzhou Siyao,Rfl Pharmaceutical |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Hisamitsu Pharmaceutical
- Novartis
- Johnson & Johnson
- Teikoku Pharma
- Mylan
- Actavis
- Mundipharma
- Henan Lingrui Pharmaceutical
- Changzhou Siyao
- Rfl Pharmaceutical
Transdermal Patch Market, By Type
- Fentanyl Transdermal Patch
- Nicotine Transdermal Patch
- Buprenorphine Transdermal Patch
- Clonidine Transdermal Patch
- Oxybutynin Transdermal Patch
- Others
Transdermal Patch Market, By Application
- Used to Stop Smoking Cigarettes
- Used to Treat High Blood Pressure
- Used to Relieve Severe Pain
- Used to Treat an Overactive Bladder
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Transdermal Patch Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Transdermal Patch Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Transdermal Patch Industry Overview
2.1 Global Transdermal Patch Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Transdermal Patch Global Import Market Analysis
2.1.2 Transdermal Patch Global Export Market Analysis
2.1.3 Transdermal Patch Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Fentanyl Transdermal Patch
2.2.2 Nicotine Transdermal Patch
2.2.3 Buprenorphine Transdermal Patch
2.2.4 Clonidine Transdermal Patch
2.2.5 Oxybutynin Transdermal Patch
2.2.6 Others
2.3.2 Used to Treat High Blood Pressure
2.3.3 Used to Relieve Severe Pain
2.3.4 Used to Treat an Overactive Bladder
2.4.2 Global Transdermal Patch Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Transdermal Patch Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Transdermal Patch Manufacturer Market Share
2.4.5 Top 10 Transdermal Patch Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Transdermal Patch Market
2.4.7 Key Manufacturers Transdermal Patch Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Transdermal Patch Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Transdermal Patch Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Transdermal Patch Market Size Categorized by Regions
4.1 Global Transdermal Patch Revenue, Sales and Market Share by Regions
4.1.1 Global Transdermal Patch Sales and Market Share by Regions (2015-2020)
4.1.2 Global Transdermal Patch Revenue and Market Share by Regions (2015-2020)
4.2 Europe Transdermal Patch Sales and Growth Rate (2015-2020)
4.3 APAC Transdermal Patch Sales and Growth Rate (2015-2020)
4.4 North America Transdermal Patch Sales and Growth Rate (2015-2020)
4.5 South America Transdermal Patch Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Transdermal Patch Sales and Growth Rate (2015-2020)
5 Europe Transdermal Patch Market Size Categorized by Countries
5.1 Europe Transdermal Patch Sales, Revenue and Market Share by Countries
5.1.1 Europe Transdermal Patch Sales by Countries (2015-2020)
5.1.2 Europe Transdermal Patch Revenue by Countries (2015-2020)
5.1.3 Germany Transdermal Patch Sales and Growth Rate (2015-2020)
5.1.4 UK Transdermal Patch Sales and Growth Rate (2015-2020)
5.1.5 France Transdermal Patch Sales and Growth Rate (2015-2020)
5.1.6 Russia Transdermal Patch Sales and Growth Rate (2015-2020)
5.1.7 Italy Transdermal Patch Sales and Growth Rate (2015-2020)
5.1.8 Spain Transdermal Patch Sales and Growth Rate (2015-2020)
5.2 Europe Transdermal Patch Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Transdermal Patch Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Transdermal Patch Sales Market Share by Type (2015-2020)
5.3.2 Europe Transdermal Patch Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Transdermal Patch Sales Market Share by Application (2015-2020)
6 Asia-Pacific Transdermal Patch Market Size Categorized by Countries
6.1 Asia-Pacific Transdermal Patch Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Transdermal Patch Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Transdermal Patch Revenue by Countries (2015-2020)
6.1.3 China Transdermal Patch Sales and Growth Rate (2015-2020)
6.1.4 Japan Transdermal Patch Sales and Growth Rate (2015-2020)
6.1.5 Korea Transdermal Patch Sales and Growth Rate (2015-2020)
6.1.6 India Transdermal Patch Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Transdermal Patch Sales and Growth Rate (2015-2020)
6.1.8 Australia Transdermal Patch Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Transdermal Patch Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Transdermal Patch Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Transdermal Patch Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Transdermal Patch Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Transdermal Patch Sales and Market Share by Application (2015-2020)
7 North America Transdermal Patch Market Size Categorized by Countries
7.1 North America Transdermal Patch Sales, Revenue and Market Share by Countries
7.1.1 North America Transdermal Patch Sales by Countries (2015-2020)
7.1.2 North America Transdermal Patch Revenue by Countries (2015-2020)
7.1.3 United States Transdermal Patch Sales and Growth Rate (2015-2020)
7.1.4 Canada Transdermal Patch Sales and Growth Rate (2015-2020)
7.1.5 Mexico Transdermal Patch Sales and Growth Rate (2015-2020)
7.2 North America Transdermal Patch Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Transdermal Patch Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Transdermal Patch Sales Market Share by Type (2015-2020)
7.3.2 North America Transdermal Patch Revenue and Revenue Share by Type (2015-2020)
7.4 North America Transdermal Patch Sales Market Share by Application (2015-2020)
8 South America Transdermal Patch Market Size Categorized by Countries
8.1 South America Transdermal Patch Sales, Revenue and Market Share by Countries
8.1.1 South America Transdermal Patch Sales by Countries (2015-2020)
8.1.2 South America Transdermal Patch Revenue by Countries (2015-2020)
8.1.3 Brazil Transdermal Patch Sales and Growth Rate (2015-2020)
8.2 South America Transdermal Patch Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Transdermal Patch Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Transdermal Patch Sales Market Share by Type (2015-2020)
8.3.2 South America Transdermal Patch Revenue and Revenue Share by Type (2015-2020)
8.4 South America Transdermal Patch Sales Market Share by Application (2015-2020)
9 Middle East and Africa Transdermal Patch Market Size Categorized by Countries
9.1 Middle East and Africa Transdermal Patch Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Transdermal Patch Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Transdermal Patch Revenue by Countries (2015-2020)
9.1.3 GCC Countries Transdermal Patch Sales and Growth Rate (2015-2020)
9.1.4 Turkey Transdermal Patch Sales and Growth Rate (2015-2020)
9.1.5 Egypt Transdermal Patch Sales and Growth Rate (2015-2020)
9.1.6 South Africa Transdermal Patch Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Transdermal Patch Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Transdermal Patch Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Transdermal Patch Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Transdermal Patch Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Transdermal Patch Sales Market Share by Application (2015-2020)
10 Global Transdermal Patch Market Segment by Type
10.1 Global Transdermal Patch Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Transdermal Patch Sales and Market Share by Type (2015-2020)
10.1.2 Global Transdermal Patch Revenue and Market Share by Type (2015-2020)
10.2 Fentanyl Transdermal Patch Sales Growth Rate and Price
10.2.1 Global Fentanyl Transdermal Patch Sales Growth Rate (2015-2020)
10.2.2 Global Fentanyl Transdermal Patch Price (2015-2020)
10.3 Nicotine Transdermal Patch Sales Growth Rate and Price
10.3.1 Global Nicotine Transdermal Patch Sales Growth Rate (2015-2020)
10.3.2 Global Nicotine Transdermal Patch Price (2015-2020)
10.4 Buprenorphine Transdermal Patch Sales Growth Rate and Price
10.4.1 Global Buprenorphine Transdermal Patch Sales Growth Rate (2015-2020)
10.4.2 Global Buprenorphine Transdermal Patch Price (2015-2020)
10.5 Clonidine Transdermal Patch Sales Growth Rate and Price
10.5.1 Global Clonidine Transdermal Patch Sales Growth Rate (2015-2020)
10.5.2 Global Clonidine Transdermal Patch Price (2015-2020)
10.6 Oxybutynin Transdermal Patch Sales Growth Rate and Price
10.6.1 Global Oxybutynin Transdermal Patch Sales Growth Rate (2015-2020)
10.6.2 Global Oxybutynin Transdermal Patch Price (2015-2020)
10.7 Others Sales Growth Rate and Price
10.7.1 Global Others Sales Growth Rate (2015-2020)
10.7.2 Global Others Price (2015-2020)
11.1 Global Transdermal PatchSales Market Share by Application (2015-2020)
11.2 Used to Stop Smoking Cigarettes Sales Growth Rate (2015-2020)
11.3 Used to Treat High Blood Pressure Sales Growth Rate (2015-2020)
11.4 Used to Relieve Severe Pain Sales Growth Rate (2015-2020)
11.5 Used to Treat an Overactive Bladder Sales Growth Rate (2015-2020)
12.1 Global Transdermal Patch Revenue, Sales and Growth Rate (2020-2027)
12.2 Transdermal Patch Market Forecast by Regions (2020-2027)
12.2.1 Europe Transdermal Patch Market Forecast (2020-2027)
12.2.2 APAC Transdermal Patch Market Forecast (2020-2027)
12.2.3 North America Transdermal Patch Market Forecast (2020-2027)
12.2.4 South America Transdermal Patch Market Forecast (2020-2027)
12.2.5 Middle East & Africa Transdermal Patch Market Forecast (2020-2027)
12.3 Transdermal Patch Market Forecast by Type (2020-2027)
12.3.1 Global Transdermal Patch Sales Forecast by Type (2020-2027)
12.3.2 Global Transdermal Patch Market Share Forecast by Type (2020-2027)
12.4 Transdermal Patch Market Forecast by Application (2020-2027)
12.4.1 Global Transdermal Patch Sales Forecast by Application (2020-2027)
12.4.2 Global Transdermal Patch Market Share Forecast by Application (2020-2027)
13 Analysis of Transdermal Patch Industry Key Manufacturers
13.1 Hisamitsu Pharmaceutical
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Hisamitsu Pharmaceutical Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Hisamitsu Pharmaceutical News
13.2 Novartis
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Novartis Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Novartis News
13.3 Johnson & Johnson
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Johnson & Johnson Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Johnson & Johnson News
13.4 Teikoku Pharma
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Teikoku Pharma Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Teikoku Pharma News
13.5 Mylan
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Mylan Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Mylan News
13.6 Actavis
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Actavis Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Actavis News
13.7 Mundipharma
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Mundipharma Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Mundipharma News
13.8 Henan Lingrui Pharmaceutical
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Henan Lingrui Pharmaceutical Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Henan Lingrui Pharmaceutical News
13.9 Changzhou Siyao
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Changzhou Siyao Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Changzhou Siyao News
13.10 Rfl Pharmaceutical
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Rfl Pharmaceutical Transdermal Patch Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Rfl Pharmaceutical News
15 Appendix